Public Company Consumer

Philip Morris International

Stamford, Connecticut, United States

Philip Morris International (PMI) is a consumer goods company working to deliver a smoke-free future and evolving its portfolio beyond tobacco and nicotine. PMI invests in developing and commercializing smoke-free products for adult consumers, including IQOS and ZYN.

Focus Areas
Smoke-free nicotine products, Heated tobacco, Oral nicotine
Website
www.pmi.com

Tracked deals

3

3 tracked deals across 2021-2022.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

3 buyout

Philip Morris International Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for Philip Morris International. 2 2021 1 2022

Supporting Data

Recent Transactions

  • Philip Morris Holland Holdings Acquires Swedish Match in Recommended Cash Offer
    November 10, 2022
    Buyer
    Philip Morris Holland Holdings B.V., Philip Morris International Inc.
    Target
    Swedish Match AB
    Industry
    Consumer Products
    Location
    Sweden
    Type
    Buyout

    Philip Morris Holland Holdings B.V. (PMHH), an affiliate of Philip Morris International (PMI), launched a recommended cash offer to acquire all shares of Swedish Match AB at SEK 106 per share. After regulatory approvals and tendering to meet deal conditions, PMHH declared the offer unconditional and began completing the acquisition, targeting delisting and compulsory redemption of remaining shares.

  • Philip Morris International to Acquire Vectura Group
    July 9, 2021
    Buyer
    Philip Morris International Inc.
    Target
    Vectura Group plc
    Industry
    Healthcare Services
    Location
    United Kingdom
    Type
    Buyout

    Philip Morris International (PMI) announced it has agreed to an all-cash, recommended offer to acquire Vectura Group plc for an enterprise value of GBP 852 million (approximately USD 1.2 billion). The deal is expected to close in the second half of 2021, subject to shareholder and regulatory approvals.

  • Philip Morris International Acquires Fertin Pharma from EQT Private Equity
    July 1, 2021
    Buyer
    Philip Morris International
    Target
    Fertin Pharma
    Seller
    EQT Private Equity, Bagger-Sørensen & Co. (Bagger-Sørensen family)
    Industry
    Pharmaceuticals
    Location
    Region of Southern Denmark, Denmark
    Type
    Buyout

    Philip Morris International has agreed to acquire Fertin Pharma, a Denmark-headquartered specialist CDMO in oral and intra-oral delivery technologies, from EQT Private Equity for a headline enterprise value of DKK 5.1 billion. Fertin Pharma — which operates sites in Denmark, Canada and India and employs more than 860 people — will strengthen PMI's smoke-free and beyond-nicotine product capabilities; the transaction is subject to customary approvals.

Related Acquisition Pages

Consumer Products Buyers & Acquisitions 1 tracked deal by Philip Morris International. Healthcare Services Buyers & Acquisitions 1 tracked deal by Philip Morris International. Pharmaceuticals Buyers & Acquisitions 1 tracked deal by Philip Morris International.

Related articles

Selling a company? Get in front of buyers like Philip Morris International

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →